Omega Therapeutics’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Omega Therapeutics is a biotechnology company that develops and commercializes novel therapeutics for the treatment of genomic diseases. Read more

Mahesh Karande's photo - President & CEO of Omega Therapeutics

President & CEO

Mahesh Karande

CEO Approval Rating

90/100

Founded:

2017

Status:

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Second Genome is seen as one of Omega Therapeutics's biggest rivals. Second Genome is headquartered in Brisbane, California, and was founded in 2009. Like Omega Therapeutics, Second Genome also works within the Biotechnology sector. Second Genome generates ∞% the revenue of Omega Therapeutics.

Spark Therapeutics is seen as one of Omega Therapeutics's top competitors. Spark Therapeutics was founded in 2011, and its headquarters is in Philadelphia, Pennsylvania. Spark Therapeutics operates in the Biotechnology industry. Spark Therapeutics has 417 more employees than Omega Therapeutics.

bluebird bio is one of Omega Therapeutics's top rivals. bluebird bio is a Public company that was founded in Cambridge, Massachusetts in 1992. bluebird bio operates in the Biotechnology industry. bluebird bio has 1,134 more employees vs. Omega Therapeutics.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $ < 1M a good estimate for Omega Therapeutics's revenue?

Acquisitions

No recent acquisitions found related to Omega Therapeutics

Omega Therapeutics Funding History

$0$85M

Since Omega Therapeutics was founded in 2017, it has participated in 2 rounds of funding. In total Omega Therapeutics has raised $85.0M. Omega Therapeutics' last funding round was on Jul 2020 for a total of $85.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Jul 2020
$85M

Flagship Pioneering

Series A
Jun 2018
--
-

Total Funding: $85M

Since Omega Therapeutics was founded in 2017, it has participated in 2 rounds of funding. In total Omega Therapeutics has raised $85.0M. Omega Therapeutics' last funding round was on Jul 2020 for a total of $85.0M

Investments

No recent investments found related to Omega Therapeutics

Omega Therapeutics News

September 23, 2019PharmaLive

Omega Therapeutics Debuts to Develop Epigenetic Drugs

Omega Therapeutics debuted with a focus on epigenetics, the study of changes in gene expression that ... See more »

Headquarters

325 Vassar Street

Cambridge, Massachusetts02139

617-949-4360

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Omega Therapeutics is a biotechnology company that develops and commercializes novel therapeutics for the treatment of genomic diseases. Omega Therapeutics was founded in 2017. Omega Therapeutics' headquarters is located in Cambridge, Massachusetts, U...

CEO

Omega Therapeutics's President & CEO, Mahesh Karande, currently has an approval rating of 90%. Omega Therapeutics's primary competitors are Second Genome, Spark Therapeutics & bluebird bio.

Website

omegatherapeutics.com

Frequently Asked Questions about Omega Therapeutics

  1. When was Omega Therapeutics founded?

    Omega Therapeutics was founded in 2017
  2. Who is Omega Therapeutics's CEO?

    Omega Therapeutics's CEO is Mahesh Karande
  3. How much revenue does Omega Therapeutics generate?

    Omega Therapeutics generates $ < 1M in revenue
  4. How much funding does Omega Therapeutics have?

    Omega Therapeutics has historically raised $85M in funding
  1. Where is Omega Therapeutics's headquarters?

    Omega Therapeutics's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Omega Therapeutics have?

    Omega Therapeutics has 33 employees
  3. What sector does Omega Therapeutics operate in?

    Omega Therapeutics is in Biotechnology
  4. Who are Omega Therapeutics's competitors?

    Omega Therapeutics's top competitors are Second Genome, Spark Therapeutics, bluebird bio